Organon & Co (OGN, $17.86) was one of top quarterly gainers, jumping +1 to $17.86 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that of them (2) charted an Uptrend while of them (7) trended down.